Lung cancer patients exhibited a log odds of -0.405, translating to an odds ratio of 0.667 (95% CI: 0.0803-5.54), with a p-value of 0.707, indicating no significant association between lung cancer and elevated NT-proBNP levels relative to the reference group. The gene discussed is NPPB; the disease is lung cancer.